1. Home
  2. ONC vs BBDO Comparison

ONC vs BBDO Comparison

Compare ONC & BBDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • BBDO
  • Stock Information
  • Founded
  • ONC 2010
  • BBDO 1943
  • Country
  • ONC Switzerland
  • BBDO Brazil
  • Employees
  • ONC N/A
  • BBDO N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • BBDO Major Banks
  • Sector
  • ONC Health Care
  • BBDO Finance
  • Exchange
  • ONC Nasdaq
  • BBDO Nasdaq
  • Market Cap
  • ONC 34.8B
  • BBDO 28.5B
  • IPO Year
  • ONC N/A
  • BBDO N/A
  • Fundamental
  • Price
  • ONC $368.19
  • BBDO $3.18
  • Analyst Decision
  • ONC Strong Buy
  • BBDO Strong Buy
  • Analyst Count
  • ONC 12
  • BBDO 4
  • Target Price
  • ONC $361.00
  • BBDO $2.55
  • AVG Volume (30 Days)
  • ONC 252.8K
  • BBDO 61.6K
  • Earning Date
  • ONC 11-06-2025
  • BBDO 10-29-2025
  • Dividend Yield
  • ONC N/A
  • BBDO 4.72%
  • EPS Growth
  • ONC N/A
  • BBDO 47.11
  • EPS
  • ONC 0.29
  • BBDO 0.38
  • Revenue
  • ONC $4,998,489,124.00
  • BBDO $16,507,289,161.00
  • Revenue This Year
  • ONC $887.89
  • BBDO $77.56
  • Revenue Next Year
  • ONC $22.45
  • BBDO $7.49
  • P/E Ratio
  • ONC $1,226.72
  • BBDO $9.03
  • Revenue Growth
  • ONC 49.15
  • BBDO 16.68
  • 52 Week Low
  • ONC $170.99
  • BBDO $1.71
  • 52 Week High
  • ONC $381.50
  • BBDO $3.21
  • Technical
  • Relative Strength Index (RSI)
  • ONC 66.75
  • BBDO 68.20
  • Support Level
  • ONC $306.60
  • BBDO $3.00
  • Resistance Level
  • ONC $381.50
  • BBDO $3.21
  • Average True Range (ATR)
  • ONC 12.71
  • BBDO 0.09
  • MACD
  • ONC 6.69
  • BBDO 0.02
  • Stochastic Oscillator
  • ONC 80.96
  • BBDO 92.75

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About BBDO Banco Bradesco Sa (each representing one Common Share)

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

Share on Social Networks: